| Cynthia L Rossi, MD | |
|
1100 Central Ave Se Fl 4b, Pmg Hospitalists, Albuquerque, NM 87106-4930 | |
| (505) 724-6124 | |
| (505) 724-6125 |
| Full Name | Cynthia L Rossi |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 1100 Central Ave Se Fl 4b, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174617567 | NPI | - | NPPES |
| 000R6502 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 97355 (New Mexico) | Primary |
| Entity Name | Los Alamos Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750330510 PECOS PAC ID: 4587661541 Enrollment ID: O20061104000041 |
News Archive
Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.
› Verified 9 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215266754 PECOS PAC ID: 3678602802 Enrollment ID: O20101202000819 |
News Archive
Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.
› Verified 9 days ago
| Entity Name | Comprehensive Hospitalist Services Of New Mexico, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447597778 PECOS PAC ID: 0941447320 Enrollment ID: O20130501000527 |
News Archive
Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20151019001400 |
News Archive
Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia L Rossi, MD Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-5356 | Cynthia L Rossi, MD 1100 Central Ave Se Fl 4b, Pmg Hospitalists, Albuquerque, NM 87106-4930 Ph: (505) 724-6124 |
News Archive
Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.
› Verified 9 days ago
Dr. Jens Oldrich Langsjoen, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: University Of New Mexico, 1 University Of New Mexico Msc 5550, Albuquerque, NM 87131 Phone: 505-951-0740 | |
Kristen D Faith, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Dr Martin Luther King Jr Ave Ne, Hospitalist Department, Albuquerque, NM 87102 Phone: 505-727-8000 | |
Jill A Slominski, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1100 Central Ave Se Fl 4b, Pmg Hospitalists, Albuquerque, NM 87106 Phone: 505-724-6124 Fax: 505-724-6125 | |
Dr. Anne E Belzowski, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Msc10 5550 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-925-0660 | |
Payal Urvij Modhia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1100 Central Ave Se Fl 4, Pmg Hospitalist, Albuquerque, NM 87106 Phone: 505-724-6124 Fax: 505-724-6125 | |
Dr. Mark Danforth Lacy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Dept Internal Medicine 1 University Nm Msc 10-5550, Albuquerque, NM 87131 Phone: 505-272-1670 Fax: 505-272-4435 | |
Janet L Blanchard, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Dr Martin Luther King Jr Ave Ne, Albuquerque, NM 87102 Phone: 505-727-8360 Fax: 505-727-8768 |